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Clinics 
Age and sex 
21 months old male patient. 
Previous history 
No preleukemia. No previous solid tumors. Inborn 
condition of note: Prematurity (borth at 33 weeks of 
gestation). 
Organomegaly 
No hepatomegaly, no splenomegaly, no enlarged lymph 
nodes. 
Blood 
WBC: 10.6X 109/l 
HB: 7.1g/dl 





Bone marrow: 84 % of blastic cells. Cytochemestry: 
peroxydase: 100% of positive blasts; butyrate estera e: 







MDR-, CD34-, CD36-, CD14-, CD4+, lineage B-, 
lineage T-. 
Diagnosis 
AML1 (FAB classification), LAM with 11q23 
abnormalities (WHO classification). 
Survival 
Date of diagnosis: 04-2004 
Treatment: Induction treatment including cytosine-
arabinoside (200 mg/m_ D+1 to D+8) and 
mitoxantrone (12 mg /m_ D+1, D+2, D+3). One 
intrathecal injection (including methotrexate, steroids, 
and cytosine-arabinoside). 
Complete remission: Yes 
Relapse: no 
Survival: 8 +months 
Karyotype 
Sample: Bone marrow 
Culture time: 24/72 h 
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Other molecular cytogenetics technics 
Fluorescence in Situ Hybridization was performed 
using a MLL dual color, break apart rearrangement 
probe and a chromosome 1 specific labeled spectrum 
green painting probe (ABBOTT). 
Other molecular cytogenetics results 
Confirmation of MLL rearrangement by the 
t(1;11)(q21;q23). 
 
Other Molecular Studies 
Results: 
MLL multiplex PCR [t(4;11), t(6;11), t(9;11), t(10;11), 
t(11;19)]: negative. ETO/AML1: negative. 




Bone marrow (MGG staining). 
 
 















Meningeal punction: no blastic cells infiltration. 
Comments 
To our knowledge, 26 cases of translocation 
t(1;11)(q21;q23) (involved the genes AF1q (1q21) and
MLL(11q23) have already been described in the 
literature. All cases were acute leukemia except for one 
secondary myelodysplastic syndrome. In 14 cases (57 
%), the translocation was the sole abnormality. The 
other 12 cases showed additional chromosomal 
abnormalities. This rare translocation is preferentially 
associated with AML4, AML5, or biphenotypic 
leukemia of infants or children. Only one case of AML 
M1/M2 in a 3-year-old female was reported with 
t(1;11)(q21;q23) as the sole karyotypic change. We 
present here the second case of AML1 with 
t(1;11)(q21;q23). The chid is in complete remission at 
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